ID PALH_ERWRD Reviewed; 453 AA. AC Q9AI65; DT 24-NOV-2009, integrated into UniProtKB/Swiss-Prot. DT 24-NOV-2009, sequence version 2. DT 02-SEP-2026, entry version 81. DE RecName: Full=Alpha-glucosidase; DE EC=3.2.1.20; GN Name=palH; OS Erwinia rhapontici (Pectobacterium rhapontici). OC Bacteria; Pseudomonadati; Pseudomonadota; Gammaproteobacteria; OC Enterobacterales; Erwiniaceae; Erwinia. OX NCBI_TaxID=55212; RN [1] RP NUCLEOTIDE SEQUENCE [GENOMIC DNA], FUNCTION IN PALATINOSE METABOLISM, RP PATHWAY, AND INDUCTION. RC STRAIN=ATCC 29283 / DSM 4484 / LMG 2688 / NCPPB 1578 / ICPB ER102 / RC CP/28; RX PubMed=11274100; DOI=10.1128/jb.183.8.2425-2430.2001; RA Boernke F., Hajirezaei M., Sonnewald U.; RT "Cloning and characterization of the gene cluster for palatinose metabolism RT from the phytopathogenic bacterium Erwinia rhapontici."; RL J. Bacteriol. 183:2425-2430(2001). RN [2] RP PROTEIN SEQUENCE OF 2-26, CATALYTIC ACTIVITY, SUBSTRATE SPECIFICITY, RP COFACTOR, ACTIVITY REGULATION, KINETIC PARAMETERS, MASS SPECTROMETRY, RP SUBUNIT, AND MUTAGENESIS OF GLU-173 AND ILE-174. RC STRAIN=ATCC 29283 / DSM 4484 / LMG 2688 / NCPPB 1578 / ICPB ER102 / RC CP/28; RX PubMed=19625389; DOI=10.1093/molbev/msp162; RA Hall B.G., Pikis A., Thompson J.; RT "Evolution and biochemistry of family 4 glycosidases: implications for RT assigning enzyme function in sequence annotations."; RL Mol. Biol. Evol. 26:2487-2497(2009). CC -!- FUNCTION: Alpha-glucosidase with broad specificity. Hydrolyzes maltose, CC palatinose, maltulose, trehalose, trehalulose, turanose, leucrose, CC sucrose and maltitol. Is not active against alpha-galactosides, e.g. CC melibiose, and alpha-mannosides. Shows an obligate requirement for an CC O-alpha-glycosidic linkage, since it is not able to cleave beta- CC glycosidic bonds (cellobiose, gentiobiose, lactose, sophorose or CC laminaribiose). Cannot hydrolyze phosphorylated alpha-glucosides CC derivatives. Seems to be involved in the degradation of palatinose, a CC sucrose isomer that is formed as a reserve material under conditions of CC excess carbon availability, sequestered in a form unavailable to CC competitors such as fungi or the host plant, and whose consumption CC appears to be postponed until the preferentially metabolized carbon CC source (e.g. sucrose) is depleted. {ECO:0000269|PubMed:11274100}. CC -!- CATALYTIC ACTIVITY: CC Reaction=Hydrolysis of terminal, non-reducing (1->4)-linked alpha-D- CC glucose residues with release of alpha-D-glucose.; EC=3.2.1.20; CC Evidence={ECO:0000269|PubMed:19625389}; CC -!- COFACTOR: CC Name=Mn(2+); Xref=ChEBI:CHEBI:29035; CC Evidence={ECO:0000269|PubMed:19625389}; CC Name=Co(2+); Xref=ChEBI:CHEBI:48828; CC Evidence={ECO:0000269|PubMed:19625389}; CC Name=Ca(2+); Xref=ChEBI:CHEBI:29108; CC Evidence={ECO:0000269|PubMed:19625389}; CC Name=Fe(2+); Xref=ChEBI:CHEBI:29033; CC Evidence={ECO:0000269|PubMed:19625389}; CC Name=Mg(2+); Xref=ChEBI:CHEBI:18420; CC Evidence={ECO:0000269|PubMed:19625389}; CC Name=Sr(2+); Xref=ChEBI:CHEBI:35104; CC Evidence={ECO:0000269|PubMed:19625389}; CC Name=Ni(2+); Xref=ChEBI:CHEBI:49786; CC Evidence={ECO:0000269|PubMed:19625389}; CC Note=Binds 1 divalent metal ion per subunit. Mn(2+) is the most CC efficient metal, but to a lesser extent, can also use Co(2+), Ca(2+), CC Fe(2+), Mg(2+), Sr(2+), and Ni(2+). Cannot use Zn(2+), Cu(2+) or CC Cr(2+). {ECO:0000269|PubMed:19625389}; CC -!- COFACTOR: CC Name=NAD(+); Xref=ChEBI:CHEBI:57540; CC Evidence={ECO:0000269|PubMed:19625389}; CC Note=Binds 1 NAD(+) per subunit. {ECO:0000269|PubMed:19625389}; CC -!- ACTIVITY REGULATION: Is inhibited by EDTA in vitro. CC {ECO:0000269|PubMed:19625389}. CC -!- BIOPHYSICOCHEMICAL PROPERTIES: CC Kinetic parameters: CC KM=8.58 mM for maltose {ECO:0000269|PubMed:19625389}; CC KM=7.31 mM for maltitol {ECO:0000269|PubMed:19625389}; CC KM=6.59 mM for trehalose {ECO:0000269|PubMed:19625389}; CC KM=3.63 mM for trehalulose {ECO:0000269|PubMed:19625389}; CC KM=22.11 mM for sucrose {ECO:0000269|PubMed:19625389}; CC KM=10.04 mM for turanose {ECO:0000269|PubMed:19625389}; CC KM=1.75 mM for maltulose {ECO:0000269|PubMed:19625389}; CC KM=5.31 mM for leucrose {ECO:0000269|PubMed:19625389}; CC KM=2.52 mM for palatinose {ECO:0000269|PubMed:19625389}; CC KM=180 uM for 4-nitrophenyl-alpha-D-glucopyranoside CC {ECO:0000269|PubMed:19625389}; CC KM=104 uM for NAD(+) {ECO:0000269|PubMed:19625389}; CC KM=47.2 uM for Mn(2+) {ECO:0000269|PubMed:19625389}; CC Vmax=1.01 umol/min/mg enzyme with maltose as substrate CC {ECO:0000269|PubMed:19625389}; CC Vmax=0.24 umol/min/mg enzyme with maltitol as substrate CC {ECO:0000269|PubMed:19625389}; CC Vmax=0.51 umol/min/mg enzyme with trehalose as substrate CC {ECO:0000269|PubMed:19625389}; CC Vmax=0.47 umol/min/mg enzyme with trehalulose as substrate CC {ECO:0000269|PubMed:19625389}; CC Vmax=0.31 umol/min/mg enzyme with sucrose as substrate CC {ECO:0000269|PubMed:19625389}; CC Vmax=0.46 umol/min/mg enzyme with turanose as substrate CC {ECO:0000269|PubMed:19625389}; CC Vmax=0.53 umol/min/mg enzyme with maltulose as substrate CC {ECO:0000269|PubMed:19625389}; CC Vmax=0.44 umol/min/mg enzyme with leucrose as substrate CC {ECO:0000269|PubMed:19625389}; CC Vmax=0.7 umol/min/mg enzyme with palatinose as substrate CC {ECO:0000269|PubMed:19625389}; CC Vmax=6.01 umol/min/mg enzyme with CC 4-nitrophenyl-alpha-D-glucopyranoside as substrate CC {ECO:0000269|PubMed:19625389}; CC -!- PATHWAY: Glycan degradation; palatinose degradation. CC {ECO:0000269|PubMed:11274100}. CC -!- SUBUNIT: Homotetramer. {ECO:0000269|PubMed:19625389}. CC -!- INDUCTION: Down-regulated by sucrose and up-regulated by palatinose. CC {ECO:0000269|PubMed:11274100}. CC -!- MASS SPECTROMETRY: Mass=50216; Method=Electrospray; CC Evidence={ECO:0000269|PubMed:19625389}; CC -!- SIMILARITY: Belongs to the glycosyl hydrolase 4 family. {ECO:0000305}. CC -!- SEQUENCE CAUTION: CC Sequence=AAK28734.1; Type=Erroneous initiation; Evidence={ECO:0000305}; CC --------------------------------------------------------------------------- CC Copyrighted by the UniProt Consortium, see https://www.uniprot.org/terms CC Distributed under the Creative Commons Attribution (CC BY 4.0) License CC --------------------------------------------------------------------------- DR EMBL; AF279280; AAK28734.1; ALT_INIT; Genomic_DNA. DR RefSeq; WP_133841662.1; NZ_AP024331.1. DR AlphaFoldDB; Q9AI65; -. DR SMR; Q9AI65; -. DR CAZy; GH4; Glycoside Hydrolase Family 4. DR OrthoDB; 9767022at2; -. DR BRENDA; 3.2.1.20; 2149. DR BRENDA; 3.2.1.86; 2149. DR SABIO-RK; Q9AI65; -. DR UniPathway; UPA01004; -. DR GO; GO:0004558; F:alpha-1,4-glucosidase activity; IEA:UniProtKB-EC. DR GO; GO:0016616; F:oxidoreductase activity, acting on the CH-OH group of donors, NAD or NADP as acceptor; IEA:InterPro. DR GO; GO:0005975; P:carbohydrate metabolic process; IEA:InterPro. DR Gene3D; 3.90.1820.10; AglA-like glucosidase; 1. DR InterPro; IPR053715; GH4_Enzyme_sf. DR InterPro; IPR001088; Glyco_hydro_4. DR InterPro; IPR022616; Glyco_hydro_4_C. DR InterPro; IPR015955; Lactate_DH/Glyco_Ohase_4_C. DR InterPro; IPR036291; NAD(P)-bd_dom_sf. DR PANTHER; PTHR32092; 6-PHOSPHO-BETA-GLUCOSIDASE-RELATED; 1. DR PANTHER; PTHR32092:SF6; ALPHA-GALACTOSIDASE; 1. DR Pfam; PF02056; Glyco_hydro_4; 1. DR Pfam; PF11975; Glyco_hydro_4C; 1. DR PRINTS; PR00732; GLHYDRLASE4. DR SUPFAM; SSF56327; LDH C-terminal domain-like; 1. DR SUPFAM; SSF51735; NAD(P)-binding Rossmann-fold domains; 1. PE 1: Evidence at protein level; KW Calcium; Carbohydrate metabolism; Cobalt; Direct protein sequencing; KW Glycosidase; Hydrolase; Iron; Magnesium; Manganese; Metal-binding; NAD; KW Nickel. FT INIT_MET 1 FT /note="Removed" FT /evidence="ECO:0000269|PubMed:19625389" FT CHAIN 2..453 FT /note="Alpha-glucosidase" FT /id="PRO_0000389548" FT ACT_SITE 172 FT /note="Proton donor" FT /evidence="ECO:0000250" FT BINDING 3..69 FT /ligand="NAD(+)" FT /ligand_id="ChEBI:CHEBI:57540" FT /evidence="ECO:0000250" FT BINDING 149 FT /ligand="substrate" FT /evidence="ECO:0000250" FT BINDING 171 FT /ligand="Mn(2+)" FT /ligand_id="ChEBI:CHEBI:29035" FT /evidence="ECO:0000250" FT BINDING 201 FT /ligand="Mn(2+)" FT /ligand_id="ChEBI:CHEBI:29035" FT /evidence="ECO:0000250" FT MUTAGEN 173 FT /note="E->S: Loss of catalytic activity." FT /evidence="ECO:0000269|PubMed:19625389" FT MUTAGEN 174 FT /note="I->V: No effect on catalytic activity." FT /evidence="ECO:0000269|PubMed:19625389" SQ SEQUENCE 453 AA; 50341 MW; 64B178085AE436AC CRC64; MATKIVLVGA GSAQFGYGTL GDIFQSRALY GSEIILHDIN PVALAVTEKT AKDFLAKEDL PFIVSATTDR RTALRGAEFV IISIEVGDRF ALWDLDWQIP QQYGIQQVYG ENGGPGGLFH SLRIIPPILD ICADVADICP DAWIFNYSNP MSRICTTVHR RFPELNFVGM CHEIASLERY LPEMLNTSFD NLSLRAGGLN HFSVLLDARY KDSGKDAYAD VRAKAPDYFA SLPGYSDILA YTRQHGKLVD TEGSTERHAL GGKDSSYPWA DRTLFKEILE KFHCMPITVD SHFGEYISWA GEVSDHRGIL DFYTFYRNYL GGVQPKIELK LKERVVSIME GILTDSGYEE AAVNIPNRGF IKQLPEFIAV EVPAIIDRKG VHGIQVDIPP GIGGLLSNQI AIHDLTAEAI IAGSRDLVIQ ALLVDSVNNQ CRAIPELVDV MISRQQPWLN YLK //